Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy

Expert Opin Drug Saf. 2022 Sep;21(9):1137-1141. doi: 10.1080/14740338.2022.2122436. Epub 2022 Sep 15.

Authors

Antonio Riccardo Buonomo¹, Nunzia Esposito¹, Isabella Di Filippo¹, Gabriele Saccone², Biagio Pinchera¹, Riccardo Scotto¹, Giuseppe Bifulco¹, Ivan Gentile¹

Affiliations

¹ Department of Clinical Medicine and Surgery, Infectious Diseases Unit, University "Federico Ii", Naples, Italy.
² Department of Neuroscience, Reproductive Science and Dentistry, School of Medicine, University of Naples Federico Ii, Naples Italy.

PMID: 36082789
DOI: 10.1080/14740338.2022.2122436

No abstract available

Keywords: COVID-19; maternal infection; monoclonal antibodies; pregnancy.

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal / adverse effects
Antibodies, Viral
COVID-19*
Female
Humans
Pregnancy
Pregnancy Complications, Infectious* / drug therapy

Substances

Antibodies, Monoclonal
Antibodies, Viral